These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 14008906)

  • 41. The suitability of various plasmin preparations for the functional assay of alpha 2-antiplasmin in plasma.
    Kluft C; Traas DW; Jie AF; Hoegee-de Nobel E
    Thromb Haemost; 1982 Dec; 48(3):320-4. PubMed ID: 6219471
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Evaluation of a latex agglutination assay method for the determination of plasmin/alpha 2 plasmin inhibitor complex].
    Murakami F; Iijima K; Nakamura K; Ikawa S
    Rinsho Byori; 1994 Jun; 42(6):643-7. PubMed ID: 8051804
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alpha 2-antiplasmin Enschede is not an inhibitor, but a substrate, of plasmin.
    Rijken DC; Groeneveld E; Kluft C; Nieuwenhuis HK
    Biochem J; 1988 Oct; 255(2):609-15. PubMed ID: 2974279
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Features of the interaction between alpha2-antiplasmin and plasminogen/plasmin].
    Hrynenko TV; Iusova OI; Zadorozhna MB; Makohonenko IeM
    Ukr Biokhim Zh (1999); 2002; 74(6):83-90. PubMed ID: 12924019
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance.
    Carpenter SL; Mathew P
    Haemophilia; 2008 Nov; 14(6):1250-4. PubMed ID: 19141165
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
    Yamasawa F; Hasegawa N; Asano K; Sayama K; Fujita H; Urano T; Aoki T; Ishizaka A; Kanazawa M; Kawashiro T
    Kokyu To Junkan; 1992 Jul; 40(7):685-90. PubMed ID: 1387724
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A coagulation of fibrinolytic study in children with nephrotic syndrome: evaluation of hypercoagulability by measuring with plasmin- alpha 2 plasmin inhibitor complex and FDP D-dimer].
    Oikawa T; Muramatsu Y; Akashi S; Usui N
    Nihon Jinzo Gakkai Shi; 1997 Mar; 39(2):144-9. PubMed ID: 9134831
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical usefulness of the measurements of plasmin-alpha 2-plasmin inhibitor complex and plasma tissue factor activity in patients with disseminated intravascular coagulation].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1996 Aug; 44(8):750-6. PubMed ID: 8816061
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elevated levels of plasmin-alpha2 antiplasmin complexes in unstable angina.
    Bayés-Genís A; Guindo J; Oliver A; Badimon L; Fiol M; Mateo J; Souto JC; Dominguez JM; Fontcuberta J; Bayés de Luna A
    Thromb Haemost; 1999 Jun; 81(6):865-8. PubMed ID: 10404758
    [TBL] [Abstract][Full Text] [Related]  

  • 50. On the structure of the stable complex between plasmin and alpha-2-antiplasmin.
    Nilsson T; Wiman B
    FEBS Lett; 1982 Jun; 142(1):111-4. PubMed ID: 6213426
    [No Abstract]   [Full Text] [Related]  

  • 51. [Concentration of thrombin antithrombin III complex and plasmin alpha 2-plasmin inhibitor complex in nephrotic syndrome].
    Kobayashi M; Katayama T; Ochiai S; Yoshida M; Kaito K; Masuoka H; Shimada T; Nishiwaki K; Sakai O
    Nihon Jinzo Gakkai Shi; 1991 Jul; 33(7):653-8. PubMed ID: 1836241
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum antiplasmin and plasmin in rheumatoid arthritis.
    THOMAS DP; DINGLE JT
    Ann Rheum Dis; 1955 Jun; 14(2):195-7. PubMed ID: 14388598
    [No Abstract]   [Full Text] [Related]  

  • 54. Hydroxyethyl starch enhances fibrinolysis in human plasma by diminishing alpha2-antiplasmin-plasmin interactions.
    Nielsen VG
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):647-56. PubMed ID: 17890952
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasmin-alpha 2-plasmin inhibitor complex and alpha 2-plasmin inhibitor in chronic subdural hematoma.
    Saito K; Ito H; Hasegawa T; Yamamoto S
    J Neurosurg; 1989 Jan; 70(1):68-72. PubMed ID: 2521247
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Hemostatic tests for the diagnosis of thrombosis. Activated coagulation and fibrinolytic factors. Detection of the protease/inhibitor complex].
    Iijima K
    Rinsho Byori; 1988 Jun; 36(6):623-6. PubMed ID: 2974894
    [No Abstract]   [Full Text] [Related]  

  • 57. [Changes in coagulation and fibrinolysis cascades upon extracorporeal circulation].
    Kanamori N; Koiwa F; Uda S
    Nihon Rinsho; 1991 Dec; 49 Suppl():81-6. PubMed ID: 1839690
    [No Abstract]   [Full Text] [Related]  

  • 58. Plasminogen-plasmin system. VII. Potentiation of antifibrinolytic action of a synthetic inhibitor, tranexamic acid, by alpha 2-macroglobulin antiplasmin.
    Abiko Y; Iwamoto M
    Biochim Biophys Acta; 1970 Sep; 214(3):411-8. PubMed ID: 4251764
    [No Abstract]   [Full Text] [Related]  

  • 59. Imbalance between thrombin and plasmin activity in disseminated intravascular coagulation. Assessment by the thrombin-antithrombin-III complex/plasmin-alpha-2-antiplasmin complex ratio.
    Kario K; Matsuo T; Kodama K; Matsuo M; Yamamoto K; Kobayashi H
    Haemostasis; 1992; 22(4):179-86. PubMed ID: 1468720
    [TBL] [Abstract][Full Text] [Related]  

  • 60. May restricted specificity of commercially available plasmin inhibitor activity assays affect correct diagnosis of antiplasmin deficiency?
    Pozzi L; Della Valle P; D'Angelo A
    Blood Coagul Fibrinolysis; 2019 Jan; 30(1):52-53. PubMed ID: 30672814
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.